FDA to allow imports of cancer drug from China amid ongoing shortage ...
#FDA #CANCER #CHEMOTHERAPY #DRUG #CHINA #USA
FDA to allow Chinese chemotherapy drugs | NewsNation Live
VIDEO COURTSEY OF NEWS NATION
FDA to allow imports of cancer drug from China amid ongoing shortage ...
MONDAY, June 5, 2023 (HealthDay News) -- With the United States facing a high number of drug shortages, a Chinese company may help to boost the supply of one in particular, the chemotherapy agent cisplatin. The U.S. Food and Drug Administration is working with the Chinese drugmaker Qilu Pharmaceutical to import the widely used cancer drug.
LINK
BACKUP REF ARTICLES:
1] FDA allowing chemotherapy drug imported from China after shortage
2] FDA Allows Imports of China-Made Chemotherapy to Ease U.S. Shortage
3] FDA Allows Chemo Imports from China; TB Patient Jailed; 'Forever’
BUSINESS-TRADE REFS:
[1] CellOrigin Biotech Announces Global Strategic Collaboration with Qilu [2022]
[2] Qilu Pharmaceutical Announces Progress of Clinical Study of QL1706
[3] Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical [2021]
COMPANY PROFILE:
[A] Qilu pharmaceutical Co. Ltd. https://en.qilu-pharma.com/
[B] Qilu Pharmaceuticals | LinkedIn
Established in 1958 and headquartered in Jinan, China, Qilu Pharmaceuticals is a large and comprehensive pharmaceutical company specializing in R&D, manufacture, sales and international trade...
https://www.linkedin.com/company/qilupharmaceuticals